Laddar...
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
BACKGROUND: Clinical application of cancer immunotherapy requires a better understanding of tumor immunogenicity and the tumor microenvironment. HLA class I molecules present antigens to CD8(+) cytotoxic cells. Their loss or downregulation is frequently found in tumors resulting in reduced T cell re...
Sparad:
| I publikationen: | Breast Cancer Res |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6907189/ https://ncbi.nlm.nih.gov/pubmed/31829264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1231-z |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|